Cocaine-induced HIV-1 expression in microglia involves sigma-1 receptors and transforming growth factor-beta1

International Immunopharmacology
Genya GekkerPhillip K Peterson

Abstract

The neuropharmacological properties of cocaine are known to be associated with the activation of sigma-1 receptors. Cocaine also has been shown to alter both cytokine production and HIV-1 expression in mononuclear phagocytes, including microglial cells. This study tested the hypothesis that sigma-1 receptors and transforming growth factor (TGF)-beta1 are involved in cocaine-induced up-regulation of HIV-1 expression in microglial cell cultures. Treatment of microglial cells with cocaine resulted in a concentration-dependent increase in viral expression assessed by measurement of p24 antigen levels in culture supernatants. This cocaine-mediated stimulation of HIV-1 expression was blocked by treatment of microglia with inhibitors of sigma-1 receptors (BD1047) and TGF-beta1 (SB-431542 and anti-TGF-beta1 antibodies). Microglia were also shown to constitutively express sigma-1 receptor mRNA. Thus, the results of this study support the notion that neuroimmunopharmacological properties of cocaine involve sigma-1 receptors and cytokines.

References

Apr 15, 2003·Clinical Microbiology Reviews·Herman FriedmanThomas W Klein
Jan 27, 2004·Journal of Neuroimmunology·Brian GardnerSherven Sharma
Oct 19, 2004·Clinical Microbiology Reviews·R Bryan RockPhillip K Peterson

❮ Previous
Next ❯

Citations

Dec 7, 2007·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·R Bryan RockPhillip K Peterson
Jul 19, 2011·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Shilpa BuchJohn Wang
Sep 1, 2012·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Renzo MancusoXavier Navarro
Apr 26, 2008·Infectious Diseases in Obstetrics and Gynecology·Howard MinkoffRobert Burk
Sep 12, 2014·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Frances ZenónLoyda M Meléndez
Jun 1, 2010·Translational Stroke Research·Aaron A Hall, Keith R Pennypacker
Jun 22, 2010·Translational Stroke Research·Christopher C LeonardoKeith R Pennypacker
Sep 16, 2015·AIDS and Behavior·Edward R HammondGlenn J Treisman
Nov 18, 2015·Journal of Neurovirology·Mudit TyagiGary L Simon
Oct 22, 2014·Expert Opinion on Therapeutic Targets·Shang-Yi A TsaiTsung-Ping Su
Jun 19, 2015·Scientific Reports·Sohn G KimDimitrios N Vatakis
Nov 26, 2008·Glia·Aaron A HallKeith R Pennypacker
Apr 30, 2011·Physiological Reviews·Helmut KettenmannAlexei Verkhratsky
Nov 6, 2015·Frontiers in Microbiology·Sabyasachi DashJui Pandhare
Jul 3, 2013·Journal of Leukocyte Biology·Sohn G KimDimitrios N Vatakis
Sep 28, 2018·Metabolic Brain Disease·Lei ZhaoYuan Zhang
Dec 17, 2018·Molecular Neurobiology·Daniel YoungerNamas Chandra
Oct 12, 2018·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Omar Vélez LópezLoyda M Meléndez
Oct 9, 2018·Frontiers in Cellular Neuroscience·Jia JiaXuechu Zhen
Feb 10, 2021·Neurochemical Research·Sanjay KumarBrian Sims
May 8, 2021·Frontiers in Pharmacology·Vikas P SukhatmeVidula V Sukhatme
Sep 15, 2021·Journal of Neurochemistry·Urszula KozlowskaMaciej Figiel
Sep 28, 2010·Trends in Pharmacological Sciences·Tsung-Ping SuArnold E Ruoho

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.